Samsung Bioepis Co., Ltd. Company Profile

✉ Email this page to a colleague

Summary for Samsung Bioepis Co., Ltd.

Patents:	0
Tradenames:	5
Ingredients:	5
BLAs:	5

Biologic Drugs for Samsung Bioepis Co., Ltd.

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Patent Expiration
Samsung Bioepis Co., Ltd.	RENFLEXIS	infliximab-abda	For Injection	761054	2017-04-21		⤷ Sign Up
Samsung Bioepis Co., Ltd.	HADLIMA	adalimumab-bwwd	Injection	761059	2019-07-23		⤷ Sign Up
Samsung Bioepis Co., Ltd.	ETICOVO	etanercept-ykro	Injection	761066	2019-04-25		⤷ Sign Up
Samsung Bioepis Co., Ltd.	ONTRUZANT	trastuzumab-dttb	For Injection	761100	2019-01-18		⤷ Sign Up
Samsung Bioepis Co., Ltd.	BYOOVIZ	ranibizumab-nuna	Injection	761202	2021-09-17		⤷ Sign Up
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.